The Latin America dry eye syndrome market size reached US$ 263.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 419.0 Million by 2032, exhibiting a growth rate (CAGR) of 5.2% during 2024-2032.
Report Attribute
|
Key Statistics
|
---|---|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 263.0 Million |
Market Forecast in 2032
|
US$ 419.0 Million |
Market Growth Rate 2024-2032 | 5.2% |
Dry eye syndrome, or keratoconjunctivitis sicca (KCS), is a medical ailment characterized by various symptoms, such as aching, discomfort, burning, redness, photophobia and irritation in the eyes. It is a chronic disorder that occurs due to the lack of adequate moisture or lubrication on the surface of the eyes. It can be treated by administering artificial tears, surgeries, medications and lacrimal plugs. Dry eye syndrome can be caused due to multiple factors, such as menopause, allergies, vitamins deficiencies, autoimmune disorders, laser surgeries and excessive screen time. It can also be prevented by wearing wraparound sunglasses or other protective eyewear.
The growth in the Latin America dry eye syndrome market can be attributed to the rising geriatric population, which is prone to chronic eye-related disorders. Dry eye syndrome is associated with various medical conditions, such as diabetes, Sjogren's syndrome, arthritis, thyroid disorders, lupus and scleroderma, which are highly prevalent in elderly patients. In addition to this, the widespread utilization of contact lenses is also increasing the occurrence of dry eye syndrome. The material of the contact lens inhibits the oxygen flow to the cornea and dries up the surface of the eyes. However, various product innovations, such as the utilization of secretagogues and neurostimulation devices to stimulate the lacrimal gland temporarily and increase the natural tear production, are providing a thrust to the market growth. In line with this, the increasing utilization of electronics, such as laptops, smartphones and television, which is leading to prolonged and excessive screen time, is also impacting the market growth. Other factors, including significant improvements in the healthcare infrastructure and diagnostic technologies, along with lack of physical activities among the masses resulting in increased oxidative stress, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each segment of the Latin America dry eye syndrome market report, along with forecasts at the regional and country levels from 2024-2032. Our report has categorized the market based on disease type, drug type, product and distribution channel.
Breakup by Disease Type:
Breakup by Drug Type:
Breakup by Product:
Breakup by Distribution Channel:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Features | Details |
---|---|
Base Year of the Analysis | 2023 |
Historical Period | 2018-2023 |
Forecast Period | 2024-2032 |
Units | US$ Million |
Segment Coverage | Disease Type, Drug Type, Product, Distribution Channel, Country |
Countries Covered | Brazil, Mexico, Argentina, Colombia, Chile, Peru, Others |
Customization Scope | 10% Free Customization |
Report Price and Purchase Option | Single User License: US$ 3699 Five User License: US$ 4699 Corporate License: US$ 5699 |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
The Latin America dry eye syndrome market was valued at US$ 263.0 Million in 2023.
We expect the Latin America dry eye syndrome market to exhibit a CAGR of 5.2% during 2024-2032.
The high prevalence of dry eye syndrome as a common symptom for numerous medical ailments, such as Sjogren’s syndrome, lupus, scleroderma, rheumatoid arthritis, etc., is primarily driving the Latin America dry eye syndrome market.
The sudden outbreak of the COVID-19 pandemic had led to a severe decline in hospital or clinic visits for mitigating the risk of coronavirus infection, thereby negatively impacting the demand for dry eye syndrome diagnosis and treatment procedures across several nations of Latin America.
Based on the disease type, the Latin America dry eye syndrome market has been segmented into evaporative and aqueous. Currently, evaporative disease holds the majority of the total market share.
Based on the drug type, the Latin America dry eye syndrome market can be divided into anti-inflammatory drugs, lubricant eye drops, and autologous serum eye drops. Among these, anti-inflammatory drugs currently exhibit a clear dominance in the market.
Based on the product, the Latin America dry eye syndrome market has been categorized into liquid drops, gel, liquid wipes, eye ointment, and others. Currently, liquid drops account for the majority of the total market share.
Based on the distribution channel, the Latin America dry eye syndrome market can be bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. Among these, hospital pharmacies hold largest market share.
On a regional level, the market has been classified into Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others, where Brazil currently dominates the Latin America dry eye syndrome market.